Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SUMO2 Antikörper

SUMO2 Reaktivität: Human IF, FACS, IHC (f) Wirt: Maus Monoclonal SUMO2-1199 unconjugated
Produktnummer ABIN6938469
  • Target Alle SUMO2 Antikörper anzeigen
    SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))
    Reaktivität
    • 101
    • 34
    • 28
    • 8
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 87
    • 22
    • 1
    Maus
    Klonalität
    • 89
    • 22
    Monoklonal
    Konjugat
    • 56
    • 12
    • 9
    • 8
    • 7
    • 7
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser SUMO2 Antikörper ist unkonjugiert
    Applikation
    • 72
    • 63
    • 41
    • 19
    • 13
    • 8
    • 8
    • 4
    • 3
    • 3
    • 2
    • 1
    Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Spezifität
    The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer's disease.
    Kreuzreaktivität (Details)
    Human. Rat. Predicted to show a broad species reactivity.
    Aufreinigung
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogen
    Recombinant human SUMO2 protein
    Klon
    SUMO2-1199
    Isotyp
    IgG1 kappa
    Top Product
    Discover our top product SUMO2 Primärantikörper
  • Applikationshinweise

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa cells. Breast carcinoma.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Konservierungsmittel
    Azide free
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Haltbarkeit
    24 months
  • Target
    SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))
    Andere Bezeichnung
    SUMO2 (SUMO2 Produkte)
    Synonyme
    HSMT3 antikoerper, SMT3B antikoerper, SMT3H2 antikoerper, SUMO3 antikoerper, Smt3A antikoerper, SMT3A antikoerper, SMT3H1 antikoerper, SUMO-3 antikoerper, Smt3B antikoerper, Smt3h2 antikoerper, sumo2 antikoerper, zgc:92241 antikoerper, SUMO2 antikoerper, SUMO-2 antikoerper, Smt3b antikoerper, hsmt3 antikoerper, smt3b antikoerper, smt3h2 antikoerper, sumo-2 antikoerper, PSMT3 antikoerper, ATSUMO2 antikoerper, MCO15.11 antikoerper, MCO15_11 antikoerper, SMALL UBIQUITIN-LIKE MODIFIER 2 antikoerper, SUM2 antikoerper, SUMO 2 antikoerper, small ubiquitin-like modifier 2 antikoerper, small ubiquitin-like modifier 2 antikoerper, small ubiquitin-like modifier 3 antikoerper, small ubiquitin-like modifier 2b antikoerper, small ubiquitin-related modifier 2 antikoerper, small ubiquitin-like modifier 2 S homeolog antikoerper, small ubiquitin-like modifier 2 L homeolog antikoerper, SUMO2 antikoerper, SUMO3 antikoerper, Sumo2 antikoerper, sumo2b antikoerper, LOC714892 antikoerper, sumo2.S antikoerper, sumo2.L antikoerper
    Hintergrund
    HSMT3, Sentrin 2, Small ubiquitin like modifier 2, Small ubiquitin like modifier protein 3, SMT3A, SMT3B, SMT3 homolog 1 (SMT3H1), SMT3 homolog 2 (SMT3H2), SMT3 homolog, SMT3 suppressor of mif two 3 homolog 1, SMT3 suppressor of mif two 3 homolog 2, SMT3 suppressor of mif two 3 homolog 3, Suppressor of mif two 3 homolog 2, Suppressor of mif two 3 homolog 3, Ubiquitin like protein SMT3A, Ubiquitin like protein SMT3B,SUMO-2
    Cellular localisation: Nuclear
    Molekulargewicht
    11-13kDa
    Gen-ID
    6613, 474005
    UniProt
    P55854
    Pathways
    Methionine Biosynthetic Process
Sie sind hier:
Kundenservice